Login to Your Account



NeuroVive Entering Chinese Market with Sihuan Alliance

By Nuala Moran
Staff Writer

Tuesday, November 27, 2012
LONDON – NeuroVive Pharmaceutical AB signed a deal for the development of its two lead mitochondria-sparing programs in China to add to a similar agreement in Europe that should see the two drugs through to commercialization in both markets.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription